Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged or poorly drugged proteins to create new ways to fight cancer. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years.
View Top Employees from Kymera TherapeuticsWebsite | http://www.kymeratx.com |
Ticker | KYMR |
Revenue | $25 million |
Funding | $396.8 million |
Employees | 207 (200 on RocketReach) |
Founded | 2016 |
Address | 500 North Beacon Street 4th Floor, Watertown, Massachusetts 02472, US |
Phone | (857) 285-5300 |
Technologies |
JavaScript,
HTML,
Twitter
+46 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Health Care, Therapeutics |
Keywords | Small Molecule Drug Discovery |
Competitors | Arvinas, CrystalGenomics, Inc., Intra-Cellular Therapies, Milestone Pharmaceuticals, Inc., Vidac Pharma |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 325414 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Kymera Therapeutics employee's phone or email?
The Kymera Therapeutics annual revenue was $25 million in 2024.
Anthony Slavin is the Vice President of Kymera Therapeutics.
200 people are employed at Kymera Therapeutics.
Kymera Therapeutics is based in Watertown, Massachusetts.
The NAICS codes for Kymera Therapeutics are [325414, 32, 325, 54, 541, 32541, 3254].
The SIC codes for Kymera Therapeutics are [87, 873].